Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
7.12% to 7.14% and revenue growth assumptions kept at 9.83%. This reflects fresh research that ties the higher target mainly to stronger Q3 product sales and updated 2025 net product sales guidance in the US$225m to US$230m range, while still flagging questions from cautious voices about how much good news is already priced in. Monitor these shifting inputs so you are not caught off guard as the Rigel story evolves. Stay updated as the Fair Value for Rigel Pharmaceuticals shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Rigel Pharmaceuticals. ?? Bullish Takeaways Jefferies moved Rigel Pharmaceuticals to a more positive stance, shifting its rating from Hold to Buy after Q3 product sales were reported and total 2025 net product sales guidance was set in the US$225m to US$230m range. The firm raised its price target meaningfully, to US$42 from US$23. This signals that, in its view, Rigel's execution and upda
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Rigel Provides Business Update and 2026 Outlook [Yahoo! Finance]Yahoo! Finance
- Rigel Provides Business Update and 2026 OutlookPR Newswire
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)PR Newswire
RIGL
Earnings
- 11/4/25 - Beat
RIGL
Sec Filings
- 1/12/26 - Form 8-K
- 12/29/25 - Form 4
- 12/10/25 - Form 8-K
- RIGL's page on the SEC website